Actively Recruiting
Discourse on the Mother's Decision Regarding the Mode of Delivery in Cases of Breech Presentation
Led by University Hospital, Strasbourg, France · Updated on 2026-01-02
200
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Breech presentation is a common occurrence in routine practice, occurring in 3-4% of all term pregnancies. Despite its frequency, breech presentation at term remains a subject of considerable controversy within the medical community. This results in differing management approaches depending on the country, the center, and the practitioner. Indeed, from a pathophysiological perspective, during a breech delivery, the fetal head is the last segment to descend into the maternal pelvis. This is the largest fetal segment in terms of volume. Furthermore, the fetal head cannot accommodate itself to the maternal pelvis through plastic deformation. This presentation can therefore lead to specific complications that may be life-threatening for the unborn child. Despite its frequency, breech presentation at term remains a subject of considerable controversy within the medical community regarding the management of labor. In the 2000s, a randomized trial called the TERM BREECH TRIAL found a neonatal benefit of planned cesarean section compared to vaginal delivery of a breech fetus (prevention of perinatal death in 1% of cases). This resulted in a significant increase in the rate of planned cesarean sections for breech presentation worldwide. However, numerous more recent studies (notably PREMODA in France) have highlighted the many biases of the Term Breech Trial, and various literature reviews (including the 2015 Cochrane review) have demonstrated lower perinatal morbidity than that found by Hannah's team. In 2020, the CNGOF (National College of Gynecologists and Obstetricians of France) published new recommendations on the management of breech presentations at the end of pregnancy, proposing vaginal delivery as a possible alternative to a planned cesarean section, provided that the patient receives clear and honest information (benefits and risks of each delivery method). The choice of delivery method must be made in consultation with the patient after a dedicated consultation. Since these recommendations were published, management practices still vary between hospitals despite fairly precise guidelines.
CONDITIONS
Official Title
Discourse on the Mother's Decision Regarding the Mode of Delivery in Cases of Breech Presentation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Gave birth in 2024 in a university hospital in the Grand Est region (Besançon, Reims, Strasbourg, Nancy)
- Delivered a breech fetus at more than 37 weeks of gestation
- Agree to complete an anonymous self-administered questionnaire
You will not qualify if you...
- Practitioner whose primary activity is not obstetrics
- Patient younger than 18 years at delivery
- Patient who had a cesarean section due to uterine scar and maternal choice
- History of uterine scarring or presence of obstruction previa preventing vaginal delivery regardless of fetal presentation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Service de Gynécologique et d'Obstétrique - CHU de Strasbourg - France
Strasbourg, France, 67091
Actively Recruiting
Research Team
M
Mary PONTVIANNE, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here